Immediate Impact
11 standout
Citing Papers
Cold and hot tumors: from molecular mechanisms to targeted therapy
2024 Standout
Deciphering the performance of macrophages in tumour microenvironment: a call for precision immunotherapy
2024 Standout
Works of Martin Meng being referenced
Phase 1 trial of TLR9 agonist lefitolimod in combination with CTLA-4 checkpoint inhibitor ipilimumab in advanced tumors.
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Martin Meng | 4 | 8 | 12 | 2 | 17 | ||
| Ryan Moslin | 4 | 7 | 5 | 3 | 21 | ||
| Jennifer Chien | 10 | 8 | 2 | 12 | |||
| Tamara Hüsser | 6 | 10 | 2 | 12 | |||
| Jaime Valentín Quiroga | 9 | 15 | 3 | 22 | |||
| Katherine H. Walsh | 7 | 13 | 3 | 15 | |||
| Soraya Kharboutli | 14 | 9 | 4 | 16 | |||
| Z. Z. Ren | 14 | 7 | 2 | 17 | |||
| Zhengliang Yue | 13 | 15 | 4 | 18 | |||
| Marilyn Wang | 5 | 9 | 4 | 18 | |||
| Rômulo Leopoldo de Paula Costa | 9 | 6 | 4 | 15 |
All Works
Loading papers...